Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Peptides & Research Compounds
1
Posts
1
Users
0
Reactions
190
Views
Topic starter
02/11/2019 11:21 am
Trying to separate three different claims about LL-37: that it is the right molecule, that it is the right dose, and that it does something useful.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
Forum consensus and published consensus diverged here about five years ago and never reconverged.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Injection site reactions are trivial until they are not, and a fresh needling technique removes half of them.
Anyone got a paper worth reading on this rather than a write-up of a paper?